Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
Identifieur interne : 000684 ( Main/Merge ); précédent : 000683; suivant : 000685Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.
Auteurs : James H. Diaz [États-Unis]Source :
- Journal of travel medicine [ 1708-8305 ] ; 2020.
Abstract
Intravenous infusions of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in experimental animals increase the numbers of angiotensin-converting enzyme 2 (ACE2) receptors in the cardiopulmonary circulation. ACE2 receptors serve as binding sites for SARS-CoV-2 virions in the lungs. Patients who take ACEIs and ARBS may be at increased risk of severe disease outcomes due to SARS-CoV-2 infections.
DOI: 10.1093/jtm/taaa041
PubMed: 32186711
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000350
- to stream PubMed, to step Curation: 000350
- to stream PubMed, to step Checkpoint: 000634
- to stream Ncbi, to step Merge: 001247
- to stream Ncbi, to step Curation: 001247
- to stream Ncbi, to step Checkpoint: 001247
Links to Exploration step
pubmed:32186711Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.</title>
<author><name sortKey="Diaz, James H" sort="Diaz, James H" uniqKey="Diaz J" first="James H" last="Diaz">James H. Diaz</name>
<affiliation wicri:level="2"><nlm:affiliation>Professor and Head, Environmental and Occupational Health Sciences, School of Public Health; Professor of Anesthesiology, School of Medicine, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, Louisiana, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Professor and Head, Environmental and Occupational Health Sciences, School of Public Health; Professor of Anesthesiology, School of Medicine, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, Louisiana</wicri:regionArea>
<placeName><region type="state">Louisiane</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32186711</idno>
<idno type="pmid">32186711</idno>
<idno type="doi">10.1093/jtm/taaa041</idno>
<idno type="wicri:Area/PubMed/Corpus">000350</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000350</idno>
<idno type="wicri:Area/PubMed/Curation">000350</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000350</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000634</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000634</idno>
<idno type="wicri:Area/Ncbi/Merge">001247</idno>
<idno type="wicri:Area/Ncbi/Curation">001247</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001247</idno>
<idno type="wicri:Area/Main/Merge">000684</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.</title>
<author><name sortKey="Diaz, James H" sort="Diaz, James H" uniqKey="Diaz J" first="James H" last="Diaz">James H. Diaz</name>
<affiliation wicri:level="2"><nlm:affiliation>Professor and Head, Environmental and Occupational Health Sciences, School of Public Health; Professor of Anesthesiology, School of Medicine, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, Louisiana, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Professor and Head, Environmental and Occupational Health Sciences, School of Public Health; Professor of Anesthesiology, School of Medicine, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, Louisiana</wicri:regionArea>
<placeName><region type="state">Louisiane</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of travel medicine</title>
<idno type="eISSN">1708-8305</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Intravenous infusions of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) in experimental animals increase the numbers of angiotensin-converting enzyme 2 (ACE2) receptors in the cardiopulmonary circulation. ACE2 receptors serve as binding sites for SARS-CoV-2 virions in the lungs. Patients who take ACEIs and ARBS may be at increased risk of severe disease outcomes due to SARS-CoV-2 infections.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000684 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000684 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= Main |étape= Merge |type= RBID |clé= pubmed:32186711 |texte= Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:32186711" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
![]() | This area was generated with Dilib version V0.6.33. | ![]() |